Asterias Biotherapeutics, Inc. Debt to Equity Ratio 2014-2018 | AST
Current and historical debt to equity ratio values for Asterias Biotherapeutics, Inc. (AST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Asterias Biotherapeutics, Inc. debt/equity for the three months ending September 30, 2018 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.01B | $0.03B | 0.22 |
| 2018-06-30 | $0.01B | $0.03B | 0.22 |
| 2018-03-31 | $0.01B | $0.03B | 0.19 |
| 2017-12-31 | $0.01B | $0.03B | 0.29 |
| 2017-09-30 | $0.01B | $0.03B | 0.37 |
| 2017-06-30 | $0.01B | $0.04B | 0.32 |
| 2017-03-31 | $0.01B | $0.04B | 0.29 |
| 2016-12-31 | $0.02B | $0.04B | 0.45 |
| 2016-09-30 | $0.03B | $0.04B | 0.65 |
| 2016-06-30 | $0.02B | $0.04B | 0.55 |
| 2016-03-31 | $0.02B | $0.03B | 0.64 |
| 2015-12-31 | $0.01B | $0.05B | 0.27 |
| 2015-09-30 | $0.01B | $0.04B | 0.29 |
| 2015-06-30 | $0.01B | $0.05B | 0.29 |
| 2015-03-31 | $0.01B | $0.04B | 0.36 |
| 2014-12-31 | $0.01B | $0.03B | 0.35 |
| 2014-09-30 | $0.02B | $0.03B | 0.57 |
| 2014-06-30 | $0.03B | $0.03B | 0.84 |
| 2014-03-31 | $0.02B | $0.05B | 0.47 |
| 2013-12-31 | $0.03B | $0.05B | 0.49 |
| 2013-09-30 | $0.01B | $-0.01B | -1.36 |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
